Specific Ion and Buffer Effects on Protein–Protein Interactions of a Monoclonal Antibody

2014 ◽  
Vol 12 (1) ◽  
pp. 179-193 ◽  
Author(s):  
D. Roberts ◽  
R. Keeling ◽  
M. Tracka ◽  
C. F. van der Walle ◽  
S. Uddin ◽  
...  
2019 ◽  
Vol 123 (4) ◽  
pp. 739-755 ◽  
Author(s):  
Jessica J. Hung ◽  
Barton J. Dear ◽  
Carl A. Karouta ◽  
Amjad A. Chowdhury ◽  
P. Douglas Godfrin ◽  
...  

2003 ◽  
Vol 49 (5) ◽  
pp. 350-356 ◽  
Author(s):  
Kyle N Seifert ◽  
William P McArthur ◽  
Arnold S Bleiweis ◽  
L Jeannine Brady

During characterization of the surface antigens of serotype III group B streptococci (GBS), a protein with an apparent Mr~ 173 500 migrating on a SDS – polyacrylamide gel was found to have an N-terminal amino acid sequence identical to that of the plasmin receptor (Plr) of group A streptococci, a surface-localized glyceraldehyde-3-phosphate dehydrogenase (GAPDH). This work begins to characterize GBS GAPDH and to assess its functional activity on the cell surface. The 1.0-kb gapC gene of GBS was amplified by PCR. plr and gapC demonstrated 87% homology. An anti-Plr monoclonal antibody reacted with GBS whole cells, suggesting GBS GAPDH is surface localized. Multiple serotypes of GBS demonstrated functional GAPDH on their surfaces. The anti-Plr monoclonal antibody recognized GBS protein bands of approximately 41 and 173.5 kDa, by Western blot. Presumably, these represent monomeric and tetrameric forms of the GAPDH molecule. GBS GAPDH was demonstrated by Western blot analysis to interact with lys- and glu-plasminogens. Fluid-phase GBS GAPDH interacted, by means of ELISA, with immobilized lys-plasminogen, glu-plasminogen, actin, and fibrinogen. Enzymatically active GAPDH, capable of binding cytoskeletal and extracellular matrix proteins, is expressed on the surface of GBS.Key words: group B streptococci, glyceraldehyde-3-phosphate dehydrogenase.


2019 ◽  
Vol 108 (8) ◽  
pp. 2517-2526 ◽  
Author(s):  
Barton J. Dear ◽  
Jessica J. Hung ◽  
Joshua R. Laber ◽  
Logan R. Wilks ◽  
Ayush Sharma ◽  
...  

2014 ◽  
Vol 11 (7) ◽  
pp. 2475-2489 ◽  
Author(s):  
D. Roberts ◽  
R. Keeling ◽  
M. Tracka ◽  
C. F. van der Walle ◽  
S. Uddin ◽  
...  

Soft Matter ◽  
2019 ◽  
Vol 15 (33) ◽  
pp. 6660-6676 ◽  
Author(s):  
Jessica J. Hung ◽  
Wade F. Zeno ◽  
Amjad A. Chowdhury ◽  
Barton J. Dear ◽  
Kishan Ramachandran ◽  
...  

Measurement and interpretation of self-diffusion of a highly concentrated mAb with different formulations in context of viscosity and protein self-interactions.


2021 ◽  
Vol 12 (1) ◽  
Author(s):  
Daniel J. Lightwood ◽  
Rebecca J. Munro ◽  
John Porter ◽  
David McMillan ◽  
Bruce Carrington ◽  
...  

AbstractWe have recently described the development of a series of small-molecule inhibitors of human tumour necrosis factor (TNF) that stabilise an open, asymmetric, signalling-deficient form of the soluble TNF trimer. Here, we describe the generation, characterisation, and utility of a monoclonal antibody that selectively binds with high affinity to the asymmetric TNF trimer–small molecule complex. The antibody helps to define the molecular dynamics of the apo TNF trimer, reveals the mode of action and specificity of the small molecule inhibitors, acts as a chaperone in solving the human TNF–TNFR1 complex crystal structure, and facilitates the measurement of small molecule target occupancy in complex biological samples. We believe this work defines a role for monoclonal antibodies as tools to facilitate the discovery and development of small-molecule inhibitors of protein–protein interactions.


Sign in / Sign up

Export Citation Format

Share Document